Building An Outcomes Trial ‘Firewall’: Who Knows What, When
Executive Summary
“Firewalls” were one option discussed for handling interim reports from cardiovascular outcomes trials at FDA’s hearing, but they create challenges in how to handle the dissemination of that information – particularly at small companies.